AmerisourceBergen: Guidance Boosted on Strength in the Low-margin U.S. Healthcare Solutions Segment By Ivo Kolchev Fundamental Analysis Read More
Humana: Peak Growth in 2023 to Moderate Only Slightly as Company Wins Market Share in a Growing Market By Ivo Kolchev Fundamental Analysis Read More
McKesson: Slowdown on End of COVID-19 Vaccine Distribution Contract to be Temporary as Company Boosts Segment Profitability Targets By Ivo Kolchev Fundamental Analysis Read More
Pfizer: Seagen Deal to Boost the Smallest Oncology Segment with Double-digit Growth By Ivo Kolchev Fundamental Analysis Read More
Booz Allen Hamilton: Strong Top-line Growth in Fiscal 2024 Clouded by Weaker Free Cash Flow Generation By Ivo Kolchev Fundamental Analysis Read More
Northrop Grumman: Temporary Margin Weakness Obscuring Strong Top-line Growth By Ivo Kolchev Fundamental Analysis Read More
Government Procurement and Inflation: Examining the Different Contract Varieties and Their Interaction with Rising Prices By Ivo Kolchev Fundamental Analysis Read More
L3Harris: Debt Repayment a Top Priority Once Aerojet Rocketdyne Purchase Closes By Ivo Kolchev Fundamental Analysis Read More
Oshkosh: New Vocational Segment's Performance to Improve in 2024 on Cost Synergies and Higher Backlog Pricing By Ivo Kolchev Fundamental Analysis Read More
Textron: Temporary Trough in Bell Performance Offset by Double-digit Revenue Growth in All Other Segments By Ivo Kolchev Fundamental Analysis Read More